| Company Name | SPERA PHARMA, Inc. |
|---|---|
| Representative | Keitaro Iwaki, President & Representative Director |
| Establishment | Apr, 2017 |
| Business Started | July, 2017 |
| Paid in Capital | 310 million yen |
| Shareholder | Astena Holdings Co., Ltd. 100% |
| Address | 17-85 Jusohonmachi 2-chome, Yodogawa-ku, Osaka 532-0024, Japan |
| TEL | +81-6-7653-6818 |
| Business | Pharmaceuticals Contract R&D and Manufacturing |
| Number of Employees | 249 (As of December 1, 2024) |
| Directors | Keitaro Iwaki, President & Representative Director Hirotoshi Naruse, Director Rami Suzuki, Outside Director |
| Auditor | Toshimitsu Isobe, Audit & Supervisory Board Member |
| Affiliated Companies | SPERA NEXUS, Inc. JITSUBO Co., Ltd.IWAKI SEIYAKU SAKURA FACTORY CO., LTD. |

page top